Cargando…
HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies
BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...
Autores principales: | Satala, Catalin Bogdan, Jung, Ioan, Stefan-van Staden, Raluca Ioana, Kovacs, Zsolt, Molnar, Calin, Bara, Tivadar, Fulop, Zsolt Zoltan, Gurzu, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596543/ https://www.ncbi.nlm.nih.gov/pubmed/33144857 http://dx.doi.org/10.1155/2020/8860174 |
Ejemplares similares
-
V-set and immunoglobulin domain containing 1 (VSIG1) as an emerging target for epithelial–mesenchymal transition of gastric cancer
por: Satala, Catalin-Bogdan, et al.
Publicado: (2022) -
Signet-Ring Cell Squamous Cell Carcinoma: A Biphenotypic Neoplasm of the Gastro-Esophageal Junction with Uncertain Biological Potential: Case Report and Literature Review
por: Satala, Catalin Bogdan, et al.
Publicado: (2023) -
In-House Validated Map of Lymph Node Stations in a Prospective Cohort of Colorectal Cancer: A Tool for a Better Preoperative Staging
por: Simu, Patricia, et al.
Publicado: (2022) -
Synchronous Colorectal Cancer: Improving Accuracy of Detection and Analyzing Molecular Heterogeneity—The Main Keys for Optimal Approach
por: Simu, Patricia, et al.
Publicado: (2021) -
Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition
por: Banias, Laura, et al.
Publicado: (2020)